sailesh's blog
Technology transfer (Lab to commercial scale):
Submitted by sailesh on Mon, 07/11/2011 - 12:53National seminar on Particulate Drug delivery systems
Submitted by sailesh on Fri, 06/17/2011 - 12:35Enhancement of dissolution using multiparticulates
Submitted by sailesh on Sun, 05/29/2011 - 11:28About 40% of the drug compounds are poorly water soluble1. This poor water solubility results in decreased rate and extent of dissolution and hence bioavailability. The formulation of a dosage form for these compounds is a challenging aspect. A number of techniques like micronization, nanonization, salt formation, complexation, solid dispersions, and use of different polymorphic form of the drug are being tried to improve the water solubility of drug compound. Each technique has its own limitations.
Antibiotic resistance – super bug
Submitted by sailesh on Sun, 05/15/2011 - 15:43Antibiotics are a particular class of anti-microbials. Anti-microbials is a general term used to cover all class of microbes like bacteria, protozoa, fungi and other such organisms. Antibiotic refers to a drug that is generally used against the infections caused due to bacteria. Starting from the pencilins, cephalosporins and other classes, a number of antibiotics that might be natural, semi-synthetic or synthetic ones are being discovered to fight against different type of infections.
invitro invivo correlation (IVIC)
Submitted by sailesh on Mon, 04/25/2011 - 03:15Pharmaceutical development of a dosage form will be easier if a system is developed that exactly mimics the conditions of human body. Unfortunately, till date, such a system does not exist. Dissolution serves the
Audio topic - polymers in drug delivery
Submitted by sailesh on Tue, 04/19/2011 - 12:56 Listen Here
[swf file="http://c450871.r71.cf2.rackcdn.com/PolymersSaileshApril2011.mp3"]
A Polymer consists of repeated subunits of monomers which may or may not be similar in structure1
They may be attached linearly or branched
High molecular weight compounds1
Process analytical technology (PAT)
Submitted by sailesh on Fri, 04/15/2011 - 15:42Hello friends, Due to inevitable circumstances, I was unable to post my second blog on invitro- invivo correlation in the previous month which I will present it this month.
Inspiring article that I would like to share
Submitted by sailesh on Thu, 03/17/2011 - 17:00Hello friends,
Scale up and post approval changes(SUPAC)
Submitted by sailesh on Tue, 03/15/2011 - 12:46This is a guidance document that comes under Chemistry manufacturing and controls section of USFDA. During formulation development, initially, development process is carried out in small batch sizes generally in the multiples of 10X i.e., small scale or lab scale. The batch size is then increased to multiples of 100X i.e., medium scale or pilot scale. In production scale or large scale, manufacturing is carried out in large numbers usually multiples of 1000X depending upon the requirement.
